An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children

Vaccine

Volumn 30, Issue 3, 2012, Pages 668-674

  Klein, Nicola P ^a   Weston, Wayde M ^b   Kuriyakose, Sherine ^c   Kolhe, Devayani ^c   Howe, Barbara ^b   Friedland, Leonard R ^b   Van Der Meeren, Olivier ^d  

^a KAISER PERMANENTE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c GlaxoSmithKline Pharmaceuticals Ltd   (India)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Booster; DTaP IPV vaccine; Measles mumps rubella vaccine; Pertussis; Poliomyelitis; Varicella vaccine

Indexed keywords

BACTERIAL ANTIGEN; BORDETELLA PERTUSSIS ANTIGEN; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA ANTIGEN; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; PEDIATRIX; POLIOMYELITIS VACCINE; TETANUS ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANOREXIA; ANTIBODY TITER; ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; DIPHTHERIA; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INJECTION SITE SWELLING; MALE; MEASLES; MULTICENTER STUDY; MUMPS; NORMAL HUMAN; OPEN STUDY; PERTUSSIS; PHASE 3 CLINICAL TRIAL; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RUBELLA; SEROLOGY; SINGLE DRUG DOSE; SYMPTOM; TETANUS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DRUG TOXICITY; FEMALE; HUMANS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; POLIOVIRUS VACCINE, INACTIVATED; VACCINATION;

EID: 84355161542     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.065     Document Type: Article

References (15)

1. General recommendations on immunization [cited 2011 June 7]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm%3Fs_cid=rr6002a1_e.
2. Meyerhoff A.S., Jacobs R.J. Do too many shots due lead to missed vaccination opportunities? Does it matter?. Prev Med 2005, 41(2):540-544.
3. Kalies H., Grote V., Verstraeten T., Hessel L., Schmitt H.-J., von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006, 25:507-512.
4. Marshall G.S., Happe L.E., Lunacsek O.E., Szymanski M.D., Woods C.R., Zahn M., et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J 2007, 26:496-500.
5. Black S., Friedland L.R., Ensor K., Weston W.M., Howe B., Klein N.P. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age. Pediatr Infect Dis J 2008, 27:341-346.
6. Black S., Friedland L.R., Schuind A., Howe B. Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years. Vaccine 2006, 24:6163-6171.
7. M-M-R® II (MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE); 2009 [cited 2011 June 7]. Available from: http://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdf.
8. VARIVAX® Varicella Virus Vaccine Live; 2001 [cited 2011 June 7]. Available from: http://www.merck.com/product/usa/pi_circulars/v/varivax/varivax_pi.pdf.
9. GlaxoSmithKline. Kinrix prescribing information; 2010 August [cited 2011 June 24]. Available from: http://us.gsk.com/products/assets/us_kinrix.pdf.
10. World Health Organisation. Standard procedure for determining immunity to poliovirus using the microneutralisation test; 1993 [WHO/EPI/GEN 93 9].
11. Newcombe R.G. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998, 17:873-890.
12. Weston W.M., Klein N.P. Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years. Expert Rev Vac 2008, 7:1309-1320.
13. Scheifele D.W., Halperin S.A., Ferguson A.C. Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens. Vaccine 2001, 19:4720-4726.
14. Rennels M.B. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin Pediatr Infect Dis 2003, 14:196-198.
15. White C.J., Kuter B.J., Hildebrand C.S., Isganitis K.L., Matthews H., Miller W.J., et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991, 87:604-610.